DPHARMA
Final Dividend (with Dividend Re-Investment Plan)
DUOPHARMA BIOTECH BERHAD |
Entitlement subject | Final Dividend (with Dividend Re-Investment Plan) |
Entitlement description | Final dividend of RM0.05 per ordinary share |
Ex-Date | 13 Jul 2020 |
Entitlement date | 14 Jul 2020 |
Entitlement time | 5:00 PM |
Financial Year End | 31 Dec 2019 |
Share transfer book & register of members will be | to closed from (both dates inclusive) for the purpose of determining the entitlement |
Payment Date | 12 Aug 2020 |
a.Securities transferred into the Depositor's Securities Account before 4:30 pm in respect of transfers | 14 Jul 2020 |
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit | |
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange. | |
Number of new shares/securities issued (units) (If applicable) |
|
Entitlement indicator | Currency |
Entitlement in Currency | Malaysian Ringgit (MYR) 0.0500 |
Options Available to Shareholders | Cash or Securities |
Cash | |
Cash^ Entitlement | |
1 | |
Tax Indicator | Tax Exempt / Non-taxable |
Currency | Malaysian Ringgit (MYR) |
Amount | 0.0500 |
or Securities | |
Re-invest Cash Entitlement into Securities | |
Entitlement | Malaysian Ringgit (MYR) 0.0500 |
Company Name |
DUOPHARMA BIOTECH BERHAD |
Issue Price per Unit | Malaysian Ringgit (MYR) 1.4100 |
Deadline To Respond | 30 Jul 2020 05:00 PM |
Securities Crediting Date | 12 Aug 2020 |
Available/Listing Date | 13 Aug 2020 |
Fractional Entitlement |
Cash in Lieu of Fraction
Malaysian Ringgit (MYR) 1.4100 per unit |
Note: You will receive Cash^ if you do not Re-invest. |
Registrar or Service Provider name, address, telephone no |
TRICOR INVESTOR & ISSUING HOUSE SERVICES SDN BHD Unit 32-01, Level 32, Tower A, Vertical Business Suite, Avenue 3, Bangsar South, No. 8, Jalan Kerinchi 59200 Kuala Lumpur Wilayah Persekutuan Malaysia Tel:0327839299 Fax:0327839222 |
Remarks : |
The Board of Directors of Duopharma Biotech Berhad ("Duopharma Biotech" or the "Company") ("Board") has declared a single-tier final dividend of RM0.05 per ordinary share in Duopharma Biotech ("Duopharma Biotech Shares") in respect of the financial year ended 31 December 2019. The Board has also determined the dividend reinvestment plan ("DRP") would apply to the final dividend. Following the above, on behalf of the Board, Mercury Securities Sdn Bhd had on 30 June 2020 announced that the issue price of the new Duopharma Biotech Shares to be issued pursuant to the DRP has been fixed at RM1.41 per Duopharma Biotech Share. This announcement is dated 30 June 2020. |
Announcement Info
Company Name | DUOPHARMA BIOTECH BERHAD |
Stock Name | DPHARMA |
Date Announced | 30 Jun 2020 |
Category | Entitlement(Notice of Book Closure) |
Reference Number | ENT-29062020-00016 |
Corporate Action ID | MY200629DRIP0001 |